<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="938ab0b5-8377-404a-8f61-5c630bda5932"><labelDrug name="Aggrenox"><Normalization><mmtx cui="C0732282" preferredWord="Aggrenox" semType="phsu, orch"/></Normalization></labelDrug><generic name="aspirin and dipyridamole"/><sentence id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.1" text="Drug Label for drug brand Aggrenox, containing aspirin and dipyridamole." type="negative"><entity charOffset="47:54" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.1.e.0" text="aspirin" type="Biomedical_Entity"><Normalization><mmtx cui="C0004057" phraseText="aspirin" preferredWord="Aspirin" semType="phsu, orch"/><RxNorm RxCui="1191"/></Normalization></entity><entity charOffset="26:34" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.1.e.1" text="aggrenox" type="Biomedical_Entity"><Normalization><mmtx cui="C0732282" phraseText="Drug Label for drug brand Aggrenox," preferredWord="Aggrenox" semType="phsu, orch"/><RxNorm RxCui="226718"/></Normalization></entity><entity charOffset="0:19" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.1.e.2" text="drug drug" type="Biomedical_Entity"><Normalization><mmtx cui="C0013231" phraseText="Drug Label for drug brand Aggrenox," preferredWord="Drugs, Non-Prescription" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="59:71" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.1.e.3" text="dipyridamole" type="Biomedical_Entity"><Normalization><mmtx cui="C0012582" phraseText="dipyridamole." preferredWord="Dipyridamole" semType="phsu, orch"/><RxNorm RxCui="3521"/></Normalization></entity><pair ddi="false" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.1.e.1" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.1.e.0"/><pair ddi="false" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.1.e.2" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.1.e.0"/><pair ddi="false" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.1.e.0" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.1.e.3"/><pair ddi="false" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.1.e.2" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.1.e.1"/><pair ddi="false" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.1.e.1" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.1.e.3"/><pair ddi="false" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.1.e.2" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.1.e.3"/></sentence><sentence id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.9" text="Aspirin is contraindicated in patients with known allergy to nonsteroidal anti-inflammatory drug products and in patients with the syndrome of asthma, rhinitis, and nasal polyps. " type="negative"><entity charOffset="0:7" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.9.e.0" text="aspirin" type="Biomedical_Entity"><Normalization><mmtx cui="C0004057" phraseText="Aspirin" preferredWord="Aspirin" semType="phsu, orch"/><RxNorm RxCui="1191"/></Normalization></entity><entity charOffset="92:105" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.9.e.1" text="drug products" type="Biomedical_Entity"><Normalization><mmtx cui="C0013227" phraseText="to nonsteroidal anti-inflammatory drug products" preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="74:91" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.9.e.2" text="anti-inflammatory" type="Biomedical_Entity"><Normalization><mmtx cui="C0003209" phraseText="to nonsteroidal anti-inflammatory drug products" preferredWord="Anti-Inflammatory Agents" semType="phsu"/><RxNorm RxCui="887"/></Normalization></entity><pair ddi="false" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.9.e.0" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.9.e.1"/><pair ddi="false" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.9.e.0" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.9.e.2"/><pair ddi="false" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.9.e.2" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.9.e.1"/></sentence><sentence biomedicalEntities="6" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.19" lineNumber="46" text="Risk factors for bleeding include the use of other drugs that increase the risk of bleeding (e.g., anticoagulants, antiplatelet agents, heparin, fibrinolytic therapy, and chronic use of NSAIDs) see Drug Interactions (7.1)." type="irregular"><entity charOffset="51:91" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.19.e.1" text="drugs that increase the risk of bleeding" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="the use of other drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="99:113" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.19.e.2" text="anticoagulants" type="Drug_Class"><Normalization><mmtx cui="C0003280" phraseText="anticoagulants," preferredWord="Anticoagulants" semType="phsu"/><RxNorm RxCui="923"/></Normalization></entity><entity charOffset="115:134" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.19.e.4" text="antiplatelet agents" type="Drug_Class"><Normalization><mmtx cui="C0085826" phraseText="antiplatelet agents," preferredWord="Antiplatelet Agents" semType="phsu"/><RxNorm RxCui="42539"/></Normalization></entity><entity charOffset="136:143" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.19.e.6" text="heparin" type="Drug"><Normalization><mmtx cui="C0019134" phraseText="heparin," preferredWord="Heparin" semType="bacs, phsu, carb"/><mmtx cui="C0770546" phraseText="heparin," preferredWord="heparin, porcine" semType="bacs, phsu, carb"/><RxNorm RxCui="5224"/></Normalization></entity><entity charOffset="145:165" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.19.e.8" text="fibrinolytic therapy" type="Drug_Class"><Normalization><RxNorm RxCui="934"/></Normalization></entity><entity charOffset="186:192" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.19.e.10" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="chronic use of NSAIDs" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="17:25" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.19.e.12" text="bleeding" type="Specific_Interaction"/><classClassMembership drugClass="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.19.e.2"/><classClassMembership drugClass="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.19.e.4"/><drugClassMembership drug="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.19.e.6" drugClass="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.19.e.1"/><classClassMembership drugClass="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.19.e.8"/><classClassMembership drugClass="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.19.e.10"/><drugInteraction id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.19.ddi.1"><interaction trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.19.e.12"><relations><relation type="hasPrecipitant"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.19.e.1"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.18" text="AGGRENOX increases the risk of bleeding. "><entity charOffset="0:8" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.18.e.0" text="AGGRENOX" type="Drug"><Normalization><mmtx cui="C0732282" phraseText="AGGRENOX" preferredWord="Aggrenox" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.19.e.1"/></sentence><sentence id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.21" text="In ESPS2 the incidence of intracranial hemorrhage was 0.6% in the AGGRENOX group, 0.5% in the extended-release dipyridamole (ER-DP) group, 0.4% in the aspirin (ASA) group and 0.4% in the placebo groups." type="negative"><entity charOffset="66:74" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.21.e.0" text="aggrenox" type="Biomedical_Entity"><Normalization><mmtx cui="C0732282" phraseText="0.6% in the AGGRENOX group," preferredWord="Aggrenox" semType="phsu, orch"/><RxNorm RxCui="226718"/></Normalization></entity><entity charOffset="111:123" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.21.e.1" text="dipyridamole" type="Biomedical_Entity"><Normalization><mmtx cui="C0012582" phraseText="0.5% in the extended-release dipyridamole (ER-DP) group," preferredWord="Dipyridamole" semType="phsu, orch"/><RxNorm RxCui="3521"/></Normalization></entity><entity charOffset="151:158" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.21.e.2" text="aspirin" type="Biomedical_Entity"><Normalization><mmtx cui="C0004057" phraseText="0.4% in the aspirin" preferredWord="Aspirin" semType="phsu, orch"/><RxNorm RxCui="1191"/></Normalization></entity><entity charOffset="160:163" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.21.e.3" text="asa" type="Biomedical_Entity"><Normalization><mmtx cui="C0004057" phraseText="(ASA) group" preferredWord="Aspirin" semType="phsu, orch"/><RxNorm RxCui="1191"/></Normalization></entity><pair ddi="false" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.21.e.0" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.21.e.1"/><pair ddi="false" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.21.e.0" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.21.e.2"/><pair ddi="false" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.21.e.0" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.21.e.3"/><pair ddi="false" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.21.e.1" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.21.e.2"/><pair ddi="false" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.21.e.1" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.21.e.3"/></sentence><sentence id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.26" text="In ESPS2 the incidence of gastrointestinal bleeding was 4.1% in the AGGRENOX group, 2.2% in the extended-release dipyridamole group, 3.2% in the aspirin group, and 2.1% in the placebo groups." type="negative"><entity charOffset="145:152" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.26.e.0" text="aspirin" type="Biomedical_Entity"><Normalization><mmtx cui="C0004057" phraseText="3.2% in the aspirin group," preferredWord="Aspirin" semType="phsu, orch"/><RxNorm RxCui="1191"/></Normalization></entity><entity charOffset="68:76" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.26.e.1" text="aggrenox" type="Biomedical_Entity"><Normalization><mmtx cui="C0732282" phraseText="4.1% in the AGGRENOX group," preferredWord="Aggrenox" semType="phsu, orch"/><RxNorm RxCui="226718"/></Normalization></entity><entity charOffset="113:125" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.26.e.2" text="dipyridamole" type="Biomedical_Entity"><Normalization><mmtx cui="C0012582" phraseText="2.2% in the extended-release dipyridamole group," preferredWord="Dipyridamole" semType="phsu, orch"/><RxNorm RxCui="3521"/></Normalization></entity><pair ddi="false" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.26.e.1" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.26.e.0"/><pair ddi="false" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.26.e.2" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.26.e.0"/><pair ddi="false" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.26.e.1" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.26.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.30" lineNumber="51" text="Because AGGRENOX contains aspirin, counsel patients who consume three or more alcoholic drinks every day about the bleeding risks involved with chronic, heavy alcohol use while taking aspirin." type="regular"><entity charOffset="115:123" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.30.e.1" text="bleeding" type="Specific_Interaction"/><entity charOffset="159:166" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.30.e.2" text="alcohol" type="Substance"><Normalization><mmtx cui="C0001975" phraseText="involved with chronic, heavy alcohol use" preferredWord="Alcohols" semType="phsu, orch"/><RxNorm RxCui="448"/></Normalization></entity><entity charOffset="184:191" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.30.e.3" text="aspirin" type="Drug"><Normalization><mmtx cui="C0004057" phraseText="taking aspirin." preferredWord="Aspirin" semType="phsu, orch"/><RxNorm RxCui="1191"/></Normalization></entity><drugInteraction id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.30.ddi.1"><interaction trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.30.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.30.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.30.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.30.e.2" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.30.e.3" trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.30.e.1" type="Specific_Interaction"/></sentence><sentence id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.36" text="Because AGGRENOX contains aspirin, AGGRENOX can cause fetal harm when administered to a pregnant woman. " type="negative"><entity charOffset="35:43" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.36.e.0" text="aggrenox" type="Biomedical_Entity"><Normalization><mmtx cui="C0732282" phraseText="AGGRENOX" preferredWord="Aggrenox" semType="phsu, orch"/><RxNorm RxCui="226718"/></Normalization></entity><entity charOffset="26:33" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.36.e.1" text="aspirin" type="Biomedical_Entity"><Normalization><mmtx cui="C0004057" phraseText="aspirin," preferredWord="Aspirin" semType="phsu, orch"/><RxNorm RxCui="1191"/></Normalization></entity><entity charOffset="8:16" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.36.e.2" text="aggrenox" type="Biomedical_Entity"><Normalization><mmtx cui="C0732282" phraseText="AGGRENOX" preferredWord="Aggrenox" semType="phsu, orch"/><RxNorm RxCui="226718"/></Normalization></entity><pair ddi="false" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.36.e.1" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.36.e.0"/><pair ddi="false" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.36.e.2" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.36.e.1"/></sentence><sentence id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.38" text="Because of the above and because of the known effects of nonsteroidal anti-inflammatory drugs (NSAIDs) on the fetal cardiovascular system (closure of the ductus arteriosus), avoid AGGRENOX in the third trimester of pregnancy see Use in Specific Populations (8.1)." type="negative"><entity charOffset="180:188" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.38.e.0" text="aggrenox" type="Biomedical_Entity"><Normalization><mmtx cui="C0732282" phraseText="AGGRENOX in the third trimester of pregnancy" preferredWord="Aggrenox" semType="phsu, orch"/><RxNorm RxCui="226718"/></Normalization></entity><entity charOffset="57:93" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.38.e.1" text="nonsteroidal anti-inflammatory drugs" type="Biomedical_Entity"><Normalization><mmtx cui="C0003211" phraseText="and because of the known effects of nonsteroidal anti-inflammatory drugs (NSAIDs)" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="402125"/></Normalization></entity><pair ddi="false" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.38.e.1" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.38.e.0"/></sentence><sentence id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.39" text="Aspirin has been shown to be teratogenic in rats (spina bifida, exencephaly, microphthalmia and coelosomia) and rabbits (congested fetuses, agenesis of skull and upper jaw, generalized edema with malformation of the head, and diaphanous skin) at oral doses of 330 mg/kg/day and 110 mg/kg/day, respectively. " type="negative"><entity charOffset="0:7" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.39.e.0" text="aspirin" type="Biomedical_Entity"><Normalization><mmtx cui="C0004057" phraseText="Aspirin" preferredWord="Aspirin" semType="phsu, orch"/><RxNorm RxCui="1191"/></Normalization></entity><entity charOffset="121:130" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.39.e.1" text="congested" type="Biomedical_Entity"><Normalization><mmtx cui="C0700150" phraseText="(congested fetuses," preferredWord="Congest" semType="strd, phsu, horm"/><RxNorm RxCui="1096425"/></Normalization></entity><pair ddi="false" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.39.e.0" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.39.e.1"/></sentence><sentence id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.40" text="These doses, which also resulted in a high resorption rate in rats (63% of implantations versus 5% in controls), are, on a mg/m2 basis, about 66 and 44 times, respectively, the dose of aspirin contained in the maximum recommended daily human dose of AGGRENOX. " type="negative"><entity charOffset="185:192" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.40.e.0" text="aspirin" type="Biomedical_Entity"><Normalization><mmtx cui="C0004057" phraseText="the dose of aspirin" preferredWord="Aspirin" semType="phsu, orch"/><RxNorm RxCui="1191"/></Normalization></entity><entity charOffset="250:258" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.40.e.1" text="aggrenox" type="Biomedical_Entity"><Normalization><mmtx cui="C0732282" phraseText="daily human dose of AGGRENOX." preferredWord="Aggrenox" semType="phsu, orch"/><RxNorm RxCui="226718"/></Normalization></entity><entity charOffset="129:134" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.40.e.2" text="basis" type="Biomedical_Entity"><Normalization><mmtx cui="C1874451" phraseText="on a mg/m2 basis," preferredWord="Basis" semType="phsu"/><RxNorm RxCui="1046801"/></Normalization></entity><pair ddi="false" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.40.e.0" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.40.e.1"/><pair ddi="false" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.40.e.2" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.40.e.0"/><pair ddi="false" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.40.e.2" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.40.e.1"/></sentence><sentence id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.41" text="Reproduction studies with dipyridamole have been performed in mice, rabbits and rats at oral doses of up to 125 mg/kg, 40 mg/kg and 1000 mg/kg, respectively (about 1, 2 and 25 times the maximum recommended daily human oral dose, respectively, on a mg/m2 basis) and have revealed no evidence of harm to the fetus due to dipyridamole. " type="negative"><entity charOffset="254:259" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.41.e.0" text="basis" type="Biomedical_Entity"><Normalization><mmtx cui="C1874451" phraseText="on a mg/m2 basis" preferredWord="Basis" semType="phsu"/><RxNorm RxCui="1046801"/></Normalization></entity><entity charOffset="26:38" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.41.e.1" text="dipyridamole" type="Biomedical_Entity"><Normalization><mmtx cui="C0012582" phraseText="studies with dipyridamole" preferredWord="Dipyridamole" semType="phsu, orch"/><RxNorm RxCui="3521"/></Normalization></entity><entity charOffset="319:331" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.41.e.2" text="dipyridamole" type="Biomedical_Entity"><Normalization><mmtx cui="C0012582" phraseText="due to dipyridamole." preferredWord="Dipyridamole" semType="phsu, orch"/><RxNorm RxCui="3521"/></Normalization></entity><pair ddi="false" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.41.e.1" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.41.e.0"/><pair ddi="false" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.41.e.0" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.41.e.2"/></sentence><sentence id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.42" text="When 330 mg aspirin/kg/day was combined with 75 mg dipyridamole/kg/day in the rat, the resorption rate approached 100%, indicating potentiation of aspirin-related fetal toxicity. " type="negative"><entity charOffset="147:154" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.42.e.0" text="aspirin" type="Biomedical_Entity"><Normalization><mmtx cui="C0004057" phraseText="potentiation of aspirin-related fetal toxicity." preferredWord="Aspirin" semType="phsu, orch"/><RxNorm RxCui="1191"/></Normalization></entity><entity charOffset="12:19" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.42.e.1" text="aspirin" type="Biomedical_Entity"><Normalization><mmtx cui="C0004057" phraseText="330 mg aspirin/kg/day" preferredWord="Aspirin" semType="phsu, orch"/><RxNorm RxCui="1191"/></Normalization></entity><entity charOffset="45:63" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.42.e.2" text="75 mg dipyridamole" type="Biomedical_Entity"><Normalization><mmtx cui="C0985611" phraseText="combined with 75 mg dipyridamole/kg/day" preferredWord="Dipyridamole 75 MG" semType="clnd"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.42.e.2" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.42.e.0"/><pair ddi="false" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.42.e.1" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.42.e.2"/></sentence><sentence id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.52" text="AGGRENOX capsules are not interchangeable with the individual components of aspirin and dipyridamole tablets." type="negative"><entity charOffset="76:83" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.52.e.0" text="aspirin" type="Biomedical_Entity"><Normalization><mmtx cui="C0004057" phraseText="not interchangeable with the individual components of aspirin" preferredWord="Aspirin" semType="phsu, orch"/><RxNorm RxCui="1191"/></Normalization></entity><entity charOffset="88:108" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.52.e.1" text="dipyridamole tablets" type="Biomedical_Entity"><Normalization><mmtx cui="C1242076" phraseText="dipyridamole tablets." preferredWord="Dipyridamole Oral Tablet [Persantine]" semType="clnd"/><RxNorm RxCui="3521"/></Normalization></entity><entity charOffset="0:8" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.52.e.2" text="aggrenox" type="Biomedical_Entity"><Normalization><mmtx cui="C0732282" phraseText="AGGRENOX capsules" preferredWord="Aggrenox" semType="phsu, orch"/><RxNorm RxCui="226718"/></Normalization></entity><pair ddi="false" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.52.e.0" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.52.e.1"/><pair ddi="false" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.52.e.2" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.52.e.0"/><pair ddi="false" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.52.e.2" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.52.e.1"/></sentence><sentence biomedicalEntities="3" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.54" lineNumber="84" text="&lt;item&gt;Co-administration with anticoagulants, antiplatelets, or NSAIDS can increase risk of bleeding (7.1)" type="irregular"><entity charOffset="91:99" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.54.e.1" text="bleeding" type="Specific_Interaction"/><entity charOffset="45:58" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.54.e.2" text="antiplatelets" type="Drug_Class"><Normalization><RxNorm RxCui="42539"/></Normalization></entity><entity charOffset="63:69" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.54.e.3" text="NSAIDS" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="NSAIDS" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="29:43" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.54.e.4" text="anticoagulants" type="Drug_Class"><Normalization><mmtx cui="C0003280" phraseText="&gt;Co-administration with anticoagulants," preferredWord="Anticoagulants" semType="phsu"/><RxNorm RxCui="923"/></Normalization></entity><drugInteraction id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.54.ddi.1"><interaction trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.54.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.54.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.54.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.54.e.4"/></relation><relation type="hasObject"><labelDrug text="Aggrenox"/><normalization><mmtx><preferredWord>Aggrenox</preferredWord><phraseText>AGGRENOX</phraseText><cuiCode>C0732282</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.54.e.2" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.54.e.3"/><pair ddi="false" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.54.e.4" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.54.e.2"/><pair ddi="false" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.54.e.4" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.54.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.54.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.54.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.54.e.4"/></sentence><sentence biomedicalEntities="1" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.55" lineNumber="86" text="&lt;item&gt;Decreased renal function can occur with co-administration with NSAIDS (7.1)" type="irregular"><entity charOffset="6:30" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.55.e.1" text="Decreased renal function" type="Specific_Interaction"/><entity charOffset="69:75" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.55.e.2" text="NSAIDS" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="with NSAIDS" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><drugInteraction id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.55.ddi.1"><interaction trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.55.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.55.e.2"/></relation><relation type="hasObject"><labelDrug text="Aggrenox"/><normalization><mmtx><preferredWord>Aggrenox</preferredWord><phraseText>AGGRENOX</phraseText><cuiCode>C0732282</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.55.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.58" lineNumber="93" text="Dipyridamole has been reported to increase the plasma levels and cardiovascular effects of adenosine. " type="regular"><entity charOffset="34:60" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.58.e.1" text="increase the plasma levels" type="Increase_Interaction"/><entity charOffset="0:12" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.58.e.2" text="Dipyridamole" type="Drug"><Normalization><mmtx cui="C0012582" phraseText="Dipyridamole" preferredWord="Dipyridamole" semType="phsu, orch"/><RxNorm RxCui="3521"/></Normalization></entity><entity charOffset="91:100" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.58.e.3" text="adenosine" type="Drug"><Normalization><mmtx cui="C0001443" phraseText="cardiovascular effects of adenosine." preferredWord="Adenosine" semType="phsu, nsba, nnon"/><RxNorm RxCui="296"/></Normalization></entity><entity charOffset="34:46|65:87" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.58.e.5" text="increase the cardiovascular effects" type="Specific_Interaction"/><drugInteraction id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.58.ddi.1"><interaction trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.58.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.58.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.58.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.58.ddi.2"><interaction trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.58.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.58.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.58.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.58.e.2" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.58.e.3" trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.58.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.59" lineNumber="93" text="Adjustment of adenosine dosage may be necessary." type="irregular"><entity charOffset="0:13|24:30" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.59.e.1" text="Adjustment of dosage" type="Caution_Interaction"/><entity charOffset="14:23" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.59.e.2" text="adenosine" type="Drug"><Normalization><mmtx cui="C0001443" phraseText="Adjustment of adenosine dosage" preferredWord="Adenosine" semType="phsu, nsba, nnon"/><RxNorm RxCui="296"/></Normalization></entity><drugInteraction id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.59.ddi.1"><interaction trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.59.e.1"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.58" text="Dipyridamole has been reported to increase the plasma levels and cardiovascular effects of adenosine. "><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.58.e.2"/></ellipsisSentence></relation><relation type="hasObject"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.59.e.2"/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="2" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.61" lineNumber="94" text="Due to the indirect effect of aspirin on the renin-angiotensin conversion pathway, the hyponatremic and hypotensive effects of ACE inhibitors may be diminished by concomitant administration of aspirin." type="regular"><entity charOffset="104:123|149:159" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.61.e.1" text="hypotensive effects diminished" type="Specific_Interaction"/><entity charOffset="193:200" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.61.e.2" text="aspirin" type="Drug"><Normalization><mmtx cui="C0004057" phraseText="diminished by concomitant administration of aspirin." preferredWord="Aspirin" semType="phsu, orch"/><RxNorm RxCui="1191"/></Normalization></entity><entity charOffset="127:141" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.61.e.3" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="hypotensive effects of ACE inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="87:99|116:123|149:159" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.61.e.5" text="hyponatremic effects diminished" type="Specific_Interaction"><Normalization><mmtx cui="C0857122" phraseText="the hyponatremic" preferredWord="hyponatremic" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.61.ddi.1"><interaction trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.61.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.61.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.61.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.61.ddi.2"><interaction trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.61.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.61.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.61.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.61.e.3" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.61.e.2" trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.61.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.63" lineNumber="95" text="Concurrent use of aspirin and acetazolamide can lead to high serum concentrations of acetazolamide (and toxicity) due to competition at the renal tubule for secretion." type="regular"><entity charOffset="56:81" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.63.e.1" text="high serum concentrations" type="Increase_Interaction"/><entity charOffset="18:25" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.63.e.2" text="aspirin" type="Drug"><Normalization><mmtx cui="C0004057" phraseText="Concurrent use of aspirin" preferredWord="Aspirin" semType="phsu, orch"/><RxNorm RxCui="1191"/></Normalization></entity><entity charOffset="85:98" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.63.e.3" text="acetazolamide" type="Drug"><Normalization><mmtx cui="C0000981" phraseText="lead to high serum concentrations of acetazolamide" preferredWord="Acetazolamide" semType="phsu, orch"/><mmtx cui="C0000981" phraseText="lead to high serum concentrations of acetazolamide" preferredWord="Acetazolamide" semType="phsu, orch"/><RxNorm RxCui="167"/></Normalization></entity><entity charOffset="104:112" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.63.e.5" text="toxicity" type="Increase_Interaction"/><drugInteraction id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.63.ddi.1"><interaction trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.63.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.63.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.63.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.63.ddi.2"><interaction trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.63.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.63.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.63.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.63.e.2" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.63.e.3" trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.63.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.65" lineNumber="96" text="Patients taking AGGRENOX in combination with anticoagulants, antiplatelets, or any substance impacting coagulation are at increased risk for bleeding. " type="regular"><entity charOffset="141:149" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.65.e.1" text="bleeding" type="Specific_Interaction"/><entity charOffset="83:114" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.65.e.2" text="substance impacting coagulation" type="Substance"><Normalization><RxNorm RxCui="8208"/></Normalization></entity><entity charOffset="61:74" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.65.e.3" text="antiplatelets" type="Drug_Class"><Normalization><RxNorm RxCui="42539"/></Normalization></entity><entity charOffset="16:24" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.65.e.4" text="AGGRENOX" type="Drug"><Normalization><mmtx cui="C0732282" phraseText="AGGRENOX in combination" preferredWord="Aggrenox" semType="phsu, orch"/><RxNorm RxCui="226718"/></Normalization></entity><entity charOffset="45:59" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.65.e.5" text="anticoagulants" type="Drug_Class"><Normalization><mmtx cui="C0003280" phraseText="with anticoagulants," preferredWord="Anticoagulants" semType="phsu"/><RxNorm RxCui="923"/></Normalization></entity><drugInteraction id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.65.ddi.1"><interaction trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.65.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.65.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.65.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.65.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.65.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.65.e.4" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.65.e.3" trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.65.e.1" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.65.e.4" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.65.e.2" trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.65.e.1" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.65.e.4" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.65.e.5" trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.65.e.1" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.65.e.3" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.65.e.2"/><pair ddi="false" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.65.e.5" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.65.e.3"/><pair ddi="false" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.65.e.5" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.65.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.66" lineNumber="96" text="Aspirin can displace warfarin from protein binding sites, leading to prolongation of both the prothrombin time and the bleeding time. " type="regular"><entity charOffset="69:110" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.66.e.1" text="prolongation of both the prothrombin time" type="Specific_Interaction"/><entity charOffset="0:7" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.66.e.2" text="Aspirin" type="Drug"><Normalization><mmtx cui="C0004057" phraseText="Aspirin" preferredWord="Aspirin" semType="phsu, orch"/><RxNorm RxCui="1191"/></Normalization></entity><entity charOffset="21:29" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.66.e.3" text="warfarin" type="Drug"><Normalization><mmtx cui="C0043031" phraseText="warfarin from protein binding sites," preferredWord="Warfarin" semType="phsu, orch, hops"/><RxNorm RxCui="11289"/></Normalization></entity><entity charOffset="69:84|115:132" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.66.e.5" text="prolongation of the bleeding time" type="Specific_Interaction"/><drugInteraction id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.66.ddi.1"><interaction trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.66.e.1"><relations><relation type="hasObject"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.66.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.66.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.66.ddi.2"><interaction trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.66.e.5"><relations><relation type="hasObject"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.66.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.66.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.66.e.2" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.66.e.3" trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.66.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.67" lineNumber="96" text="Aspirin can increase the anticoagulant activity of heparin, increasing bleeding risk." type="regular"><entity charOffset="12:47" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.67.e.1" text="increase the anticoagulant activity" type="Specific_Interaction"/><entity charOffset="51:58" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.67.e.2" text="heparin" type="Drug"><Normalization><mmtx cui="C0019134" phraseText="the anticoagulant activity of heparin," preferredWord="Heparin" semType="bacs, phsu, carb"/><mmtx cui="C0770546" phraseText="the anticoagulant activity of heparin," preferredWord="heparin, porcine" semType="bacs, phsu, carb"/><mmtx cui="C0019134" phraseText="the anticoagulant activity of heparin," preferredWord="Heparin" semType="bacs, phsu, carb"/><mmtx cui="C0770546" phraseText="the anticoagulant activity of heparin," preferredWord="heparin, porcine" semType="bacs, phsu, carb"/><RxNorm RxCui="5224"/></Normalization></entity><entity charOffset="0:7" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.67.e.3" text="Aspirin" type="Drug"><Normalization><mmtx cui="C0004057" phraseText="Aspirin" preferredWord="Aspirin" semType="phsu, orch"/><RxNorm RxCui="1191"/></Normalization></entity><entity charOffset="71:79" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.67.e.5" text="bleeding" type="Specific_Interaction"/><drugInteraction id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.67.ddi.1"><interaction trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.67.e.1"><relations><relation type="hasObject"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.67.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.67.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.67.ddi.2"><interaction trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.67.e.5"><relations><relation type="hasObject"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.67.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.67.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.67.e.3" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.67.e.2" trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.67.e.1" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.67.e.3" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.67.e.2" trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.67.e.5" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.69" lineNumber="97" text="Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels." type="regular"><entity charOffset="84:119" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.69.e.1" text="decrease in the total concentration" type="Decrease_Interaction"/><entity charOffset="0:14" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.69.e.2" text="Salicylic acid" type="Drug"><Normalization><mmtx cui="C0036079" phraseText="Salicylic acid" preferredWord="Salicylic Acid" semType="phsu, orch"/><RxNorm RxCui="9525"/></Normalization></entity><entity charOffset="123:132" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.69.e.3" text="phenytoin" type="Drug"><Normalization><mmtx cui="C0031507" phraseText="of phenytoin" preferredWord="Phenytoin" semType="phsu, orch"/><RxNorm RxCui="8183"/></Normalization></entity><entity charOffset="140:157|172:178" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.69.e.5" text="increase in serum levels" type="Increase_Interaction"/><entity charOffset="158:171" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.69.e.6" text="valproic acid" type="Drug"><Normalization><mmtx cui="C0042291" phraseText="an increase in serum valproic acid levels." preferredWord="Valproic Acid" semType="phsu, orch"/><mmtx cui="C0042291" phraseText="an increase in serum valproic acid levels." preferredWord="Valproic Acid" semType="phsu, orch"/><RxNorm RxCui="11118"/></Normalization></entity><drugInteraction id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.69.ddi.1"><interaction trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.69.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.69.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.69.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.69.ddi.2"><interaction trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.69.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.69.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.69.e.6"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.69.e.2" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.69.e.3" trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.69.e.1" type="Decrease_Interaction"/><pair ddi="true" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.69.e.2" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.69.e.6" trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.69.e.5" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.71" lineNumber="98" text="The hypotensive effects of beta blockers may be diminished by the concomitant administration of aspirin due to inhibition of renal prostaglandins, leading to decreased renal blood flow and salt and fluid retention." type="regular"><entity charOffset="4:23|48:58" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.71.e.1" text="hypotensive effects diminished" type="Specific_Interaction"/><entity charOffset="27:40" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.71.e.2" text="beta blockers" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="The hypotensive effects of beta blockers" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="96:103" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.71.e.3" text="aspirin" type="Drug"><Normalization><mmtx cui="C0004057" phraseText="diminished by the concomitant administration of aspirin" preferredWord="Aspirin" semType="phsu, orch"/><RxNorm RxCui="1191"/></Normalization></entity><entity charOffset="158:184" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.71.e.5" text="decreased renal blood flow" type="Specific_Interaction"/><entity charOffset="189:193|204:213" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.71.e.7" text="salt retention" type="Specific_Interaction"/><entity charOffset="198:213" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.71.e.9" text="fluid retention" type="Specific_Interaction"/><drugInteraction id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.71.ddi.1"><interaction trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.71.e.1"><relations><relation type="hasObject"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.71.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.71.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.71.ddi.2"><interaction trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.71.e.5"><relations><relation type="hasObject"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.71.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.71.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.71.ddi.3"><interaction trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.71.e.7"><relations><relation type="hasObject"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.71.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.71.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.71.ddi.4"><interaction trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.71.e.9"><relations><relation type="hasObject"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.71.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.71.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.71.e.2" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.71.e.3" trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.71.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.73" lineNumber="99" text="Dipyridamole may counteract the anticholinesterase effect of cholinesterase inhibitors, thereby potentially aggravating myasthenia gravis." type="regular"><entity charOffset="120:137" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.73.e.1" text="myasthenia gravis" type="Specific_Interaction"><Normalization><mmtx cui="C0026896" phraseText="myasthenia gravis." preferredWord="Myasthenia Gravis" semType="dsyn"/></Normalization></entity><entity charOffset="0:12" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.73.e.2" text="Dipyridamole" type="Drug"><Normalization><mmtx cui="C0012582" phraseText="Dipyridamole" preferredWord="Dipyridamole" semType="phsu, orch"/><RxNorm RxCui="3521"/></Normalization></entity><entity charOffset="61:86" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.73.e.3" text="cholinesterase inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0008425" phraseText="the anticholinesterase effect of cholinesterase inhibitors," preferredWord="Cholinesterase Inhibitors" semType="phsu, orch"/><RxNorm RxCui="8895"/></Normalization></entity><drugInteraction id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.73.ddi.1"><interaction trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.73.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.73.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.73.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.73.e.2" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.73.e.3" trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.73.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.75" lineNumber="100" text="The effectiveness of diuretics in patients with underlying renal or cardiovascular disease may be diminished by the concomitant administration of aspirin due to inhibition of renal prostaglandins, leading to decreased renal blood flow and salt and fluid retention." type="regular"><entity charOffset="4:17|98:108" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.75.e.1" text="effectiveness diminished" type="Decrease_Interaction"><Normalization><mmtx cui="C0007222" phraseText="cardiovascular disease" preferredWord="Cardiovascular Diseases" semType="dsyn"/></Normalization></entity><entity charOffset="59:64|83:90" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.75.e.2" text="renal disease" type="SPAN"><Normalization><mmtx cui="C0007222" phraseText="cardiovascular disease" preferredWord="Cardiovascular Diseases" semType="dsyn"/></Normalization></entity><entity charOffset="146:153" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.75.e.3" text="aspirin" type="Drug"><Normalization><mmtx cui="C0004057" phraseText="diminished by the concomitant administration of aspirin" preferredWord="Aspirin" semType="phsu, orch"/><RxNorm RxCui="1191"/></Normalization></entity><entity charOffset="68:90" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.75.e.4" text="cardiovascular disease" type="SPAN"><Normalization><mmtx cui="C0007222" phraseText="cardiovascular disease" preferredWord="Cardiovascular Diseases" semType="dsyn"/></Normalization></entity><entity charOffset="21:30" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.75.e.5" text="diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="The effectiveness of diuretics" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="208:234" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.75.e.7" text="decreased renal blood flow" type="Specific_Interaction"/><entity charOffset="239:243|254:263" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.75.e.9" text="salt retention" type="Specific_Interaction"/><entity charOffset="248:263" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.75.e.11" text="fluid retention" type="Specific_Interaction"/><drugInteraction id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.75.ddi.1"><interaction trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.75.e.1"><relations><relation type="hasContext"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.75.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.75.e.5"/></relation><relation type="hasContext"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.75.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.75.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.75.ddi.2"><interaction trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.75.e.7"><relations><relation type="hasContext"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.75.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.75.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.75.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.75.e.4"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.75.ddi.3"><interaction trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.75.e.9"><relations><relation type="hasContext"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.75.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.75.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.75.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.75.e.4"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.75.ddi.4"><interaction trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.75.e.11"><relations><relation type="hasContext"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.75.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.75.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.75.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.75.e.4"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.75.e.2, Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.75.e.4" ddi="true" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.75.e.5" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.75.e.3" trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.75.e.1" type="Decrease_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.77" lineNumber="101" text="Salicylate can inhibit renal clearance of methotrexate, leading to bone marrow toxicity, especially in the elderly or renal impaired." type="regular"><entity charOffset="15:38" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.77.e.1" text="inhibit renal clearance" type="Increase_Interaction"><Normalization><mmtx cui="C0018790" phraseText="inhibit" preferredWord="Cardiac Arrest" semType="dsyn"/></Normalization></entity><entity charOffset="107:114" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.77.e.2" text="elderly" type="SPAN"/><entity charOffset="0:10" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.77.e.3" text="Salicylate" type="Drug_Class"><Normalization><mmtx cui="C0036075" phraseText="Salicylate" preferredWord="salicylate" semType="phsu, orch"/><mmtx cui="C0036077" phraseText="Salicylate" preferredWord="Salicylates" semType="phsu, orch"/><RxNorm RxCui="9522"/></Normalization></entity><entity charOffset="42:54" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.77.e.4" text="methotrexate" type="Drug"><Normalization><mmtx cui="C0025677" phraseText="renal clearance of methotrexate," preferredWord="Methotrexate" semType="phsu, orch"/><RxNorm RxCui="6851"/></Normalization></entity><entity charOffset="118:132" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.77.e.5" text="renal impaired" type="SPAN"/><entity charOffset="67:87" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.77.e.7" text="bone marrow toxicity" type="Specific_Interaction"><Normalization><mmtx cui="C0948168" phraseText="leading to bone marrow toxicity," preferredWord="bone marrow toxicity" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.77.ddi.1"><interaction trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.77.e.1"><relations><relation type="hasContext"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.77.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.77.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.77.e.4"/></relation><relation type="hasContext"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.77.e.5"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.77.ddi.2"><interaction trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.77.e.7"><relations><relation type="hasContext"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.77.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.77.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.77.e.4"/></relation><relation type="hasContext"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.77.e.5"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.77.e.2, Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.77.e.5" ddi="true" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.77.e.3" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.77.e.4" trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.77.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.79" lineNumber="102" text="The concurrent use of aspirin with other NSAIDs may increase bleeding or lead to decreased renal function." type="regular"><entity charOffset="61:69" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.79.e.1" text="bleeding" type="Specific_Interaction"/><entity charOffset="22:29" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.79.e.2" text="aspirin" type="Drug"><Normalization><mmtx cui="C0004057" phraseText="The concurrent use of aspirin" preferredWord="Aspirin" semType="phsu, orch"/><RxNorm RxCui="1191"/></Normalization></entity><entity charOffset="41:47" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.79.e.3" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="with other NSAIDs" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="81:105" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.79.e.5" text="decreased renal function" type="Specific_Interaction"/><drugInteraction id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.79.ddi.1"><interaction trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.79.e.1"><relations><relation type="hasObject"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.79.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.79.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.79.ddi.2"><interaction trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.79.e.5"><relations><relation type="hasObject"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.79.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.79.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.79.e.2" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.79.e.3" trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.79.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.81" lineNumber="103" text="Moderate doses of aspirin may increase the effectiveness of oral hypoglycemic drugs, leading to hypoglycemia." type="regular"><entity charOffset="30:56" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.81.e.1" text="increase the effectiveness" type="Increase_Interaction"/><entity charOffset="18:25" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.81.e.2" text="aspirin" type="Drug"><Normalization><mmtx cui="C0004057" phraseText="Moderate doses of aspirin" preferredWord="Aspirin" semType="phsu, orch"/><RxNorm RxCui="1191"/></Normalization></entity><entity charOffset="60:83" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.81.e.3" text="oral hypoglycemic drugs" type="Drug_Class"><Normalization><mmtx cui="C0020616" phraseText="the effectiveness of oral hypoglycemic drugs," preferredWord="Hypoglycemic Agents" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="96:108" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.81.e.5" text="hypoglycemia" type="Specific_Interaction"><Normalization><mmtx cui="C0020615" phraseText="leading to hypoglycemia." preferredWord="Hypoglycemia" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.81.ddi.1"><interaction trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.81.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.81.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.81.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.81.ddi.2"><interaction trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.81.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.81.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.81.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.81.e.2" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.81.e.3" trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.81.e.1" type="Increase_Interaction"/></sentence><sentence id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.82" text="Uricosuric Agents (probenecid and sulfinpyrazone). " type="negative"><entity charOffset="0:17" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.82.e.0" text="uricosuric agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0041983" phraseText="Uricosuric Agents" preferredWord="Uricosuric Agents" semType="phsu"/><RxNorm RxCui="11016"/></Normalization></entity><entity charOffset="34:48" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.82.e.1" text="sulfinpyrazone" type="Biomedical_Entity"><Normalization><mmtx cui="C0038742" phraseText="sulfinpyrazone" preferredWord="Sulfinpyrazone" semType="phsu, orch"/><RxNorm RxCui="10205"/></Normalization></entity><entity charOffset="19:29" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.82.e.2" text="probenecid" type="Biomedical_Entity"><Normalization><mmtx cui="C0033209" phraseText="(probenecid" preferredWord="Probenecid" semType="phsu, orch"/><RxNorm RxCui="8698"/></Normalization></entity><pair ddi="false" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.82.e.0" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.82.e.1"/><pair ddi="false" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.82.e.0" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.82.e.2"/><pair ddi="false" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.82.e.2" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.82.e.1"/></sentence><sentence biomedicalEntities="1" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.83" lineNumber="104" text="Salicylates antagonize the uricosuric action of uricosuric agents." type="irregular"><anaphoraRelation><antecedentSentence ID="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.82" Text="Uricosuric Agents (probenecid and sulfinpyrazone). "/><anaphoraEntity charOffset="48:65" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.83.e.1" text="uricosuric agents" type="Expression"/><antecedentEntity charOffset="0:17" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.82.e.1" text="Uricosuric Agents" type="Drug_Class"/></anaphoraRelation><entity charOffset="12:44" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.83.e.3" text="antagonize the uricosuric action" type="Specific_Interaction"/><entity charOffset="0:11" id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.83.e.4" text="Salicylates" type="Drug_Class"><Normalization><mmtx cui="C0036077" phraseText="Salicylates" preferredWord="Salicylates" semType="phsu, orch"/><RxNorm RxCui="9522"/></Normalization></entity><drugInteraction id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.83.ddi.1"><interaction trigger="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.83.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.83.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.83.e.4"/></relation><relation type="hasObject"><labelDrug text="Aggrenox"/><normalization><mmtx><preferredWord>Aggrenox</preferredWord><phraseText>AGGRENOX</phraseText><cuiCode>C0732282</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.83.e.4" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.83.e.1"/><pair ddi="true" e1="labelDrug" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.83.e.1"/><pair ddi="true" e1="labelDrug" e2="Dailymed.938ab0b5-8377-404a-8f61-5c630bda5932.s.83.e.4"/></sentence><positiveExamples number="25"/><negativeExamples number="41"/></document>